-
Rhinogram, ZappRx, HEALTHeLINK, And More: News From February 2019
Clinical Research News | February was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Rhinogram, ZappRx, HEALTHeLINK, and more.
Feb 27, 2019
-
It’s About Time Clinical Research Sites Get Serious About Quality Management Systems
Clinical Research News | It's About Time | Leading clinical research sites have evolved so that they can deliver both patients and quality. Sites that want to survive, much less grow, have to keep up.
Feb 26, 2019
-
Patient-Centricity Takes Center Stage At SCOPE 2019
Clinical Research News | The quest for patient-centricity in clinical trials was the prevailing theme at the 10th Annual Summit for Clinical Ops Executives (SCOPE) held this week in Orlando.
Feb 21, 2019
-
Bring-Your-Own-Device In Clinical Trials: Achieving High Quality Data At Lower Cost
Clinical Research News Contributed Commentary | Today, bring-your-own-device protocol is used in less than 10% of clinical studies, despite strong evidence this is precisely the situation where it would be most effective to control costs, improve compliance and enhance data integrity. As a result, the industry is missing out on a strategy that would ultimately benefit consumers and pharmaceutical companies by accelerating the development of new drugs.
Feb 21, 2019
-
Three Reasons Why Mobile Technology Is A Secret Weapon For Patient Engagement And Study Success
Clinical Research News Contributed Commentary | The use of mobile technology in clinical trials is becoming increasingly prevalent, most notably in collecting eCOA data. Its role, however, in improving patient engagement throughout an entire study is a lesser known area, and an opportunity for differentiation.
Feb 20, 2019
-
Saama Partners With LLS To Advance Study Operations For Beat AML Master Trial
Clinical Research News Brief | Saama announced a new partnership with The Leukemia & Lymphoma Society (LLS) to accelerate the development of novel acute myeloid leukemia (AML) therapies through its Beat AML Master Clinical Trial.
Feb 19, 2019
